Ligand validation:6DHN

NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE

NAI is a Ligand Of Interest in 6DHN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DHN_NAI_E_603	46%	2%	0.181	0.915	4.76	1.9	19	8	8	0	100%	1
6DHN_NAI_C_604	39%	2%	0.203	0.908	4.81	1.87	20	9	4	0	100%	1
6DHN_NAI_D_603	34%	2%	0.214	0.9	4.74	1.82	19	5	5	0	100%	1
6DHN_NAI_A_603	33%	2%	0.222	0.902	4.72	2.1	19	8	4	0	100%	1
6DHN_NAI_F_605	32%	2%	0.224	0.897	4.75	2.06	19	11	8	0	100%	1
6DHN_NAI_B_603	27%	2%	0.232	0.882	4.68	2.13	20	10	12	0	100%	1
6DHN_NAI_B_604	6%	2%	0.338	0.783	4.7	1.81	18	6	3	0	100%	0.7166
6DHN_NAI_F_601	3%	2%	0.404	0.734	4.71	2.15	19	10	9	0	100%	0.6909
6DHN_NAI_A_604	3%	2%	0.409	0.725	4.71	2.2	19	8	6	0	100%	0.7039
6DHN_NAI_D_604	2%	2%	0.386	0.692	4.71	2.01	19	9	4	0	100%	0.7573
6DHN_NAI_C_603	2%	2%	0.419	0.669	4.77	1.95	19	5	4	0	100%	0.6061
6DHN_NAI_F_603	1%	2%	0.488	0.636	4.73	1.85	20	7	3	0	100%	0.6198
6DHD_NAI_F_603	69%	43%	0.146	0.962	1.01	1.2	2	3	3	0	100%	1
9CP7_NAI_A_501	100%	55%	0.041	0.986	0.66	1.06	-	2	2	0	100%	1
4PLZ_NAI_A_402	100%	46%	0.048	0.993	0.9	1.18	-	4	3	0	100%	1
5W8K_NAI_B_402	100%	32%	0.044	0.988	1.22	1.47	5	8	0	0	100%	1
9CP8_NAI_A_501	100%	51%	0.043	0.985	0.88	1.02	1	2	2	0	100%	1
4PLF_NAI_A_401	100%	21%	0.049	0.991	1.29	2.02	6	9	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.